ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MAGED TAMAN MD

Endocrinology, Diabetes Metabolism

15,701

$733K

510
430 are 65+

8%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 42%

$47
Average prescription price

Avg: $91

DENNIS KRAUSS M.D.

Endocrinology, Diabetes Metabolism

9,482

$1.13M

856
674 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

50%
prescriptions for brand name drugs

Avg: 42%

$119
Average prescription price

Avg: $91

SUDHIR BANSAL MD

Endocrinology, Diabetes Metabolism

9,003

$742K

415
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 42%

$82
Average prescription price

Avg: $91

VALERIE THOMAS M.D.

Endocrinology, Diabetes Metabolism

7,787

$818K

622
488 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 42%

$105
Average prescription price

Avg: $91

ROBERTO ORTIZ M.D.

Endocrinology, Diabetes Metabolism

7,355

$675K

503
386 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 42%

$92
Average prescription price

Avg: $91

MAGDI SALMON M.D.

Endocrinology, Diabetes Metabolism

7,017

$462K

392
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 42%

$66
Average prescription price

Avg: $91

ROBERT DOBRZYNSKI M.D.

Endocrinology, Diabetes Metabolism

6,828

$799K

729
569 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 42%

$117
Average prescription price

Avg: $91

NATHALIE CAMPBELL

Endocrinology, Diabetes Metabolism

6,677

$656K

516
374 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 42%

$98
Average prescription price

Avg: $91

FRANK D'ALESSANDRO M.D.

Endocrinology, Diabetes Metabolism

5,879

$478K

422
361 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 42%

$81
Average prescription price

Avg: $91

CHARLES KAHN M.D.

Endocrinology, Diabetes Metabolism

5,724

$670K

466
377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 42%

$117
Average prescription price

Avg: $91

ANDREA SOSA MELO M.D.

Endocrinology, Diabetes Metabolism

4,665

$313K

308
205 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 42%

$67
Average prescription price

Avg: $91

BASILIA RAMIREZ M.D.

Endocrinology, Diabetes Metabolism

4,623

$205K

299
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 42%

$44
Average prescription price

Avg: $91

BEATRIZ DEMORANVILLE MD

Endocrinology, Diabetes Metabolism

3,012

$338K

281
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 42%

$112
Average prescription price

Avg: $91

IVANA LUKACOVA-ZIB M.D.

Endocrinology, Diabetes Metabolism

2,784

$343K

253
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 42%

$123
Average prescription price

Avg: $91

MICHAEL HEIN M.D.

Endocrinology, Diabetes Metabolism

2,524

$313K

407
324 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 42%

$124
Average prescription price

Avg: $91

JOSEPH TUCCI M.D.

Endocrinology, Diabetes Metabolism

2,364

$265K

244
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

53%
prescriptions for brand name drugs

Avg: 42%

$112
Average prescription price

Avg: $91

JUDITH GILMORE M.D.

Endocrinology, Diabetes Metabolism

2,314

$225K

117
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

55%
prescriptions for brand name drugs

Avg: 42%

$97
Average prescription price

Avg: $91

VICKY CHENG M.D.

Endocrinology, Diabetes Metabolism

1,952

$273K

199
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

49%
prescriptions for brand name drugs

Avg: 42%

$140
Average prescription price

Avg: $91

HARIKRISHNA BHATT M.D.

Endocrinology, Diabetes Metabolism

1,796

$211K

203
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 42%

$117
Average prescription price

Avg: $91

PAUL LEVINSON MD

Endocrinology, Diabetes Metabolism

1,671

$201K

128
87 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 42%

$120
Average prescription price

Avg: $91

HILARY WHITLATCH M.D.

Endocrinology, Diabetes Metabolism

952

$123K

99
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 42%

$130
Average prescription price

Avg: $91

GEETHA GOPALAKRISHNAN MD

Endocrinology, Diabetes Metabolism

721

$86.5K

104
65 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

56%
prescriptions for brand name drugs

Avg: 42%

$120
Average prescription price

Avg: $91

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank